Novoron Bioscience

United States
Wonewoc, Wisconsin, United States, 92101

Company profile

Novoron Bioscience company profile

Novoron Bioscience develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS). Our novel LRP-focused science enables hope for treatment of conditions for which no current therapies exist. We’re advancing multiple biological therapeutics that treat pathologies of the CNS, including tauopathies (Alzheimer’s, CTE, TBI, etc.), acute spinal cord injury (orphan drug indication), and demyelinating conditions (multiple sclerosis, NMO, etc.).

Business identity

Contact email
[email protected]
Phone number
2065011420
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2014-01-10

Headquarters

Postal code
92101
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
15
Total equity funding
$12.5M
Last funding
Grant / $2.5M / 2026-01-06
Last equity funding
Seed / $9.5M
Investors
4
Lead investors
4
Founders
3
Articles
14

Founders and investors

Founders

A. Taylor BrightShawn GahrTravis Stiles

Lead investors

Backstage CapitalNational Institute on AgingNational Institutes of HealthTwo Bear Capital

Investors

Backstage CapitalNational Institute on AgingNational Institutes of HealthTwo Bear Capital